Your session is about to expire
← Back to Search
Low Level Laser Therapy Device
Lasercap SD for Male Pattern Baldness
N/A
Recruiting
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
25 years and older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 26 weeks
Awards & highlights
Study Summary
This trial aims to study the effects of low level laser therapy (LLLT) devices on promoting hair growth in individuals with androgenetic alopecia (AGA). The study will compare a low-fl
Who is the study for?
This trial is for men and women aged 25 or older with Androgenetic Alopecia (commonly known as male pattern baldness), who haven't treated it recently, or have stopped previous treatments for at least 6 months. Men should be in the early to moderate stages of hair loss, while women can also join if they're experiencing certain patterns of thinning. Participants must have skin types I to IV according to the Fitzpatrick scale.Check my eligibility
What is being tested?
The study tests three different scalp treatments using laser caps: a fake 'Sham' LaserCap that doesn't emit real lasers, a 'LaserCap SD' with low energy emission, and a 'LaserCap HD+' with high energy emission. The goal is to see if higher energy levels from these caps can increase hair density more effectively than lower levels or no treatment.See study design
What are the potential side effects?
Since this trial involves non-invasive laser therapy devices, side effects are expected to be minimal. However, potential side effects might include scalp irritation or redness due to light exposure from the laser devices.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 25 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 26 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~26 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Target area total hair count at 26 weeks via phototrichogram
Secondary outcome measures
Hair growth rate at 26 weeks via phototrichogram
Physician assessed improvement via global photography at 26 weeks
Target area terminal hair count at 26 weeks via phototrichogram
+1 moreTrial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Lasercap SDExperimental Treatment1 Intervention
Low fluence LLLT
Group II: Lasercap HD+Experimental Treatment1 Intervention
High fluence LLLT
Group III: Sham LaserCapPlacebo Group1 Intervention
Sham device
Find a Location
Who is running the clinical trial?
Transdermal Cap, Inc.Industry Sponsor
University of ArizonaLead Sponsor
516 Previous Clinical Trials
148,421 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are patients currently eligible to enroll in this research study?
"As stated on clinicaltrials.gov, this research endeavor is presently seeking participants. Initially shared on June 1st, 2022, the latest revision occurred on May 3rd, 2024."
Answered by AI
What is the total number of subjects being examined in this particular research investigation?
"Indeed, the details on clinicaltrials.gov reveal that this investigation is currently in need of volunteers. The study was initially published on June 1st, 2022 and had its most recent update on May 3rd, 2024. It aims to recruit a total of 50 participants at one designated site."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger